0.86
Finanzdaten der Compass Therapeutics Inc-Aktie (CMPX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
32.91%
26.98
|
20.30 | 17.99 | 15.82 | 21.07 |
| Depreciation and Amortization |
40.00%
0.021
|
0.015 | 0.017 | 0.019 | 0.10 |
| Operating Income/Loss |
32.91%
-26.98
|
-20.30 | -17.99 | -15.82 | -21.07 |
| Net Income/Loss |
37.33%
-25.15
|
-18.32 | -15.72 | -14.26 | -19.88 |
| Basic Average Shares |
0.21%
186.80
|
186.40 | 9.15 | 168.78 | 138.28 |
| Basic Earnings Per Share |
30.00%
-0.13
|
-0.10 | -0.08 | -0.08 | -0.14 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):